A novel 2,6-diisopropylphenyl-docosahexaenoamide conjugate induces apoptosis in T cell acute lymphoblastic leukemia cell lines

Biochemical and Biophysical Research Communications

Volumn 411, Issue 2, 2011, Pages 427-432

  Altenburg, Jeffrey D ^a   Harvey, Kevin A ^a   McCray, Sharon ^a   Xu, Zhidong ^a   Siddiqui, Rafat A ^a,b,c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conjugate; DHA; Leukemia; Omega 3; Propofol

Indexed keywords

2,6 DIISOPROPYLPHENYL DOCOSAHEXAENOAMIDE; AMIDE; CASPASE 3; CASPASE 7; CHEMOKINE RECEPTOR CXCR4; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; T CELL ACUTE LYMPHOBLASTIC LEUKEMIA; T LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CELL PROLIFERATION; DOCOSAHEXAENOIC ACIDS; HUMANS; JURKAT CELLS; MITOCHONDRIAL MEMBRANES; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, CXCR4;

EID: 79960841044     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.172     Document Type: Article

References (24)

1. Bradley M.O., Swindell C.S., Anthony F.H., Witman P.A., Devanesan P., Webb N.L., Baker S.D., Wolff A.C., Donehower R.C. Tumor targeting by conjugation of DHA to paclitaxel. J Control Release 2001, 74:233-236.
2. Takahashi M., Fukutake M., Isoi T., Fukuda K., Sato H., Yazawa K., Sugimura T., Wakabayashi K. Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid. Carcinogenesis 1997, 18:1337-1342.
3. Zerouga M., Stillwell W., Jenski L.J. Synthesis of a novel phosphatidylcholine conjugated to docosahexaenoic acid and methotrexate that inhibits cell proliferation. Anticancer Drugs 2002, 13:301-311.
4. Altenburg J.D., Bieberich A.A., Terry C., Harvey K.A., Vanhorn J.F., Xu Z., Davisson V.J., Siddiqui R.A. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone. BMC Cancer 2011, 11:149.
5. Calviello G., Di Nicuolo F., Serini S., Piccioni E., Boninsegna A., Maggiano N., Ranelletti F.O., Palozza P. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil. Cancer Chemother. Pharmacol. 2005, 55:12-20.
6. Ding W.Q., Liu B., Vaught J.L., Palmiter R.D., Lind S.E. Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Mol. Cancer Ther. 2006, 5:1864-1872.
7. Narayanan N.K., Narayanan B.A., Reddy B.S. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors. Int. J. Oncol. 2005, 26:785-792.
8. Tuller E.R., Brock A.L., Yu H., Lou J.R., Benbrook D.M., Ding W.Q. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells. Biochem. Pharmacol. 2009, 77:1480-1486.
9. Wynter M.P., Russell S.T., Tisdale M.J. Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs. In Vivo 2004, 18:543-547.
10. Harvey K.A., Xu Z., Whitley P., Davisson V.J., Siddiqui R.A. Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells. Bioorg. Med. Chem. 2010, 18:1866-1874.
11. Siddiqui R.A., Zerouga M., Wu M., Castillo A., Harvey K., Zaloga G.P., Stillwell W. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells. Breast Cancer Res. 2005, 7:R645-R654.
12. Mammoto T., Mukai M., Mammoto A., Yamanaka Y., Hayashi Y., Mashimo T., Kishi Y., Nakamura H. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett. 2002, 184:165-170.
13. Siddiqui R.A., Jenski L.J., Harvey K.A., Wiesehan J.D., Stillwell W., Zaloga G.P. Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. Biochem. J. 2003, 371:621-629.
14. Tsuchiya M., Asada A., Arita K., Utsumi T., Yoshida T., Sato E.F., Utsumi K., Inoue M. Induction and mechanism of apoptotic cell death by propofol in HL-60 cells. Acta Anaesthesiol. Scand. 2002, 46:1068-1074.
15. Vitale A., Guarini A., Chiaretti S., Foa R. The changing scene of adult acute lymphoblastic leukemia. Curr. Opin. Oncol. 2006, 18:652-659.
16. Altenburg J.D., Siddiqui R.A. Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells. Mol. Cancer Res. 2009, 7:1013-1020.
17. Balasubramanian S.V., Campbell R.B., Straubinger R.M. Propofol, a general anesthetic, promotes the formation of fluid phase domains in model membranes. Chem. Phys. Lipids 2002, 114:35-44.
18. Williams E.E., Jenski L.J., Stillwell W. Docosahexaenoic acid (DHA) alters the structure and composition of membranous vesicles exfoliated from the surface of a murine leukemia cell line. Biochim. Biophys. Acta 1998, 1371:351-362.
19. Chen Y., Stamatoyannopoulos G., Song C.Z. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 2003, 63:4801-4804.
20. Darash-Yahana M., Pikarsky E., Abramovitch R., Zeira E., Pal B., Karplus R., Beider K., Avniel S., Kasem S., Galun E., Peled A. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. Faseb J. 2004, 18:1240-1242.
21. Dewan M.Z., Ahmed S., Iwasaki Y., Ohba K., Toi M., Yamamoto N. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed. Pharmacother. 2006, 60:273-276.
22. Fernandis A.Z., Prasad A., Band H., Klosel R., Ganju R.K. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 2004, 23:157-167.
23. Helbig G., Christopherson K.W., Bhat-Nakshatri P., Kumar S., Kishimoto H., Miller K.D., Broxmeyer H.E., Nakshatri H. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 2003, 278:21631-21638.
24. Kang H., Watkins G., Parr C., Douglas-Jones A., Mansel R.E., Jiang W.G. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res. 2005, 7:R402-410.